Katherine Simbaña Rivera: Understanding Thromboembolic Risk After COVID-19
Katherine Simbaña Rivera, Personal docente investigador at Universidad de Las Palmas de Gran Canaria, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Frontiers in Cardiovascular Medicine, adding:
“New publication in Frontiers in Cardiovascular Medicine.
Cardiovascular complications remain one of the most important long-term consequences following COVID-19.
In our latest study, we contribute new evidence to better understand the relationship between SARS-CoV-2 infection and thromboembolic events, a topic with significant implications for patient care and public health.
This publication reflects the value of multidisciplinary collaboration and the importance of continuing to investigate the long-term effects of emerging diseases beyond the acute phase.
My sincere thanks to Jesús Endara-Mina for his leadership throughout this project, and to all co-authors and collaborators who contributed their expertise, time, and commitment to this work.
Scientific progress is built through teamwork, critical thinking, and the shared goal of improving health outcomes through evidence.”
Title: Associated thromboembolic events to the post COVID syndrome: a systematic review and meta-analysis
Authors: Jesús Endara-Mina, Cristopher-Josue Escudero, Cesar Intriago, Lisseth Coloma-Ramirez, Wilson Cabrera, Rosa Gonzaga, Sebastian Fuentes, Dario Chicaiza, Carlos Carvajal, Rafael Lopez-Carrera, Belen Baño-Jimenez, Jordy Ruilova, Erick Atahualpa, Josue Aldaz, Mayuri Quishpe, Katherine Simbaña-Rivera
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 29, 2026, 15:21Kanchan K Banerjee: Rusfertide Earns NCCN Category 1 Recommendation for Polycythemia Vera
-
Sep 29, 2026, 15:06Faizan Khan։ The Worldwide Burden of Venous Thromboembolism
-
Sep 29, 2026, 14:59Global Von Willebrand Disease Diversity Webinar Now Available on EHC YouTube – EHC
-
Sep 29, 2026, 14:43Mary Cushman: Apply to Shape Scientific Publishing as ISTH Associate Editor
-
Sep 29, 2026, 14:32Honoring Women Leaders Advancing Research, Care, and Innovation in Thrombosis and Hemostasis – Seminars in Thrombosis and Hemostasis
-
Sep 29, 2026, 14:20Nathan Connell: Key Takeaways from the 8th Aland Island Meeting on von Willebrand Disease
-
Sep 29, 2026, 14:09Mariusz Ratajczak: Are We Inadvertently Destroying the True Regenerative Power of PRP by Discarding the Plasma?
-
Sep 29, 2026, 14:00Nithin M: Proximal Splenic Artery Embolization Prior to Shunt-Directed Variceal Therapy
-
Sep 29, 2026, 13:12Wolfgang Miesbach: Teclistamab Targets the Source of Pathogenic Autoantibodies